Genotyping Industry Statistics

In the following post, we will explore key statistics and insights shaping the genotyping industry. From the market value projections to dominant players and emerging trends, the genotyping market is poised for significant growth driven by technological advancements and diverse applications. Join us as we dissect the data driving this dynamic sector.

Statistic 1

"The global genotyping market was valued at USD 7.24 billion in 2020."

Statistic 2

"The genotyping market is expected to reach USD 11.84 billion by 2026, at a CAGR of 8.22%."

Statistic 3

"The expansion of the market is primarily driven by technological advancements and the decreasing prices of DNA sequencing."

Statistic 4

"Polymerase Chain Reaction (PCR) was the most commonly used technology in the genotyping market in 2020."

Statistic 5

"Pharmaceutical research was the largest application segment for genotyping in 2019."

Statistic 6

"North America dominates the genotyping market due to advancing technologies."

Statistic 7

"Asia-Pacific's genotyping market is expected to grow at the highest CAGR from 2021 to 2026."

Statistic 8

"Major players in the genotyping market include Illumina Inc., Thermo Fisher Scientific, QIAGEN NV, Agilent Technologies, and Danaher Corporation."

Statistic 9

"In 2019, Illumina held the largest market share (~29%) in the genotyping sector."

Statistic 10

"The use of genotyping in personalized medicine was a major driver for the market in 2019."

Statistic 11

"The agricultural biotechnology application of genotyping is expected to reach a CAGR of 22.6% from 2021 to 2028."

Statistic 12

"Sequencing technologies represent the fastest-growing technology segment in the genotyping industry."

Statistic 13

"Pharmacogenomics is projected to be the fastest growing application segment of genotyping."

Statistic 14

"The demand for genotyping in disease diagnostics is expected to significantly increase from 2021-2028."

Statistic 15

"Increasing funds in genomics research is also a key driver for the growth of the genotyping market."

Statistic 16

"Small fragment analysis accounted for around 21.1% of the genotyping market in 2020."

Statistic 17

"The genotyping market for animals is projected to reach USD 1.88 billion by 2024."

Statistic 18

"The genotyping market for livestock animals has a projected CAGR of 10.2% from 2019-2024."

Statistic 19

"The livestock genotyping market's primary grow driver include increasing global demand for animal-derived protein."

Statistic 20

"Genotyping services held the largest share of the Animal Genotyping Market in 2019."

In conclusion, the global genotyping market is experiencing significant growth driven by technological advancements, decreasing DNA sequencing costs, and expanding applications across various industries. Key players such as Illumina Inc., Thermo Fisher Scientific, and QIAGEN NV are dominating the market, with personalized medicine and pharmacogenomics emerging as major drivers for market expansion. Regions like North America and Asia-Pacific are poised for substantial growth, particularly in sectors such as pharmaceutical research, agricultural biotechnology, disease diagnostics, and animal genotyping. The increasing emphasis on genomics research and the adoption of sequencing technologies further propel the market forward, showcasing a promising future for the genotyping industry.